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Abstract	23	
	Cell-intrinsic	immune	mechanisms	control	intracellular	pathogens	that	infect	eukaryotes.	The	24	
intracellular	pathogen	Mycobacterium	tuberculosis	(Mtb)	evolved	to	withstand	cell-autonomous	25	
immunity	to	cause	persistent	infections	and	disease.	A	potent	inducer	of	cell-autonomous	immunity	is	26	
the	lymphocyte-derived	cytokine	IFNg.	While	the	production	of	IFNg by	T	cells	is	essential	to	protect	27	
against	Mtb,	it	is	not	capable	of	fully	eradicating	Mtb	infection.	This	suggests	that	Mtb	evades	a	subset	28	
of	IFNg-mediated	antimicrobial	responses,	yet	what	mechanisms	Mtb	resists	remains	unclear.	The	IFNg-29	
inducible	Guanylate	binding	proteins	(GBPs)	are	key	host	defense	proteins	able	to	control	infections	30	
with	intracellular	pathogens.	GBPs	were	previously	shown	to	directly	restrict	Mycobacterium	bovis	BCG	31	
yet	their	role	during	Mtb	infection	has	remained	unknown.	Here,	we	examine	the	importance	of	a	32	
cluster	of	five	GBPs	on	mouse	chromosome	3	in	controlling	Mycobacterial	infection.	While	M.	bovis	BCG	33	
is	directly	restricted	by	GBPs,	we	find	that	the	GBPs	on	chromosome	3	do	not	contribute	to	the	control	34	
of	Mtb	replication	or	the	associated	host	response	to	infection.	The	differential	effects	of	GBPs	during	35	
Mtb	versus	M.	bovis	BCG	infection	is	at	least	partially	explained	by	the	absence	of	the	ESX1	secretion	36	
system	from	M.	bovis	BCG,	since	Mtb	mutants	lacking	the	ESX1	secretion	system	become	similarly	37	
susceptible	to	GBP-mediated	immune	defense.	Therefore,	this	specific	genetic	interaction	between	the	38	
murine	host	and	Mycobacteria	reveals	a	novel	function	for	the	ESX1	virulence	system	in	the	evasion	of	39	
GBP-mediated	immunity.			40	
	41	
	42	
	43	
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Introduction	45	
	46	
Eukaryotic	cells	control	intracellular	pathogens	using	a	variety	of	cell	intrinsic	immune	pathways	(1).	47	
These	innate	mechanisms	allow	the	cell	to	rapidly	detect,	target	and	destroy	invading	pathogens,	48	
preventing	the	spread	of	an	infection.		The	immune	pathways	controlling	innate	immunity	arose	early	in	49	
the	evolution	of	the	eukaryota,	providing	ample	time	for	the	selection	of	pathogens	that	express	50	
mechanisms	to	bypass	cell-autonomous	immunity	(2).	This	long-term	arms	race	has	produced	a	myriad	51	
of	interactions	between	immune	effectors	and	pathogen	countermeasures	that	determine	the	outcome	52	
of	an	infection.	53	
	 Mycobacterium	tuberculosis	(Mtb)	has	become	highly	adapted	to	its	human	host,	as	it	spread	54	
globally	along	with	human	migrations	over	tens	of	thousands	of	years	(3,	4).		As	much	as	one-third	of	the	55	
human	population	has	been	exposed	to	Mtb,	which	causes	a	persistent	infection	than	can	last	for	years,	56	
or	even	decades,	despite	a	robust	immune	response	that	eradicates	less	pathogenic	mycobacteria	(5).		57	
While	immunity	controls	Mtb	growth	and	prevents	disease	in	most	individuals,	a	subset	will	develop	58	
active	tuberculosis	(TB),	a	disease	that	kills	an	estimated	1.8	million	each	year	(6).		Disease	progression	is	59	
influenced	by	a	variety	of	genetic	and	environment	factors,	but	ultimately	is	determined	by	the	interplay	60	
between	host	immunity	and	bacterial	virulence	systems(5,	7).			61	
	 In	the	host,	the	development	of	a	robust	T	cell	response	and	the	production	of	the	cytokine	IFNg	62	
are	important	for	the	control	TB	infection	and	disease	(5,	8).	Humans	with	inherited	mutations	affecting	63	
either	the	development	or	expression	of	this	response	are	highly	susceptible	to	mycobacterial	infections	64	
including	TB	(9).	This	susceptibility	is	faithfully	modeled	in	mice,	where	the	loss	of	IFNg	signaling	65	
promotes	disease	by	at	least	two	distinct	mechanisms	(10,	11).		IFNg	is	an	important	immunomodulatory	66	
cytokine,	and	its	loss	results	in	uncontrolled	IL1	production	and	neutrophil	recruitment,	driving	both	67	
bacterial	replication	and	tissue	damage	(10,	12).		Perhaps	more	importantly,	IFNg	stimulates	cell-intrinsic	68	
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immune	pathways	in	phagocytes,	which	is	critical	for	the	control	of	intracellular	bacterial	growth	(13,	69	
14).	Thus,	IFNg	is	a	pleotropic	cytokine	that	controls	direct	antimicrobial	resistance	and	disease	70	
tolerance,	both	of	which	are	essential	to	survive	Mtb	infection.		71	
While	many	of	the	immunomodulatory	effects	of	IFNg	have	been	elucidated,	the	IFNg-induced	72	
factors	that	control	Mtb	replication	remain	comparatively	obscure.		IFNg-induced	oxygen	and	nitrogen	73	
radical	generation	limits	Mtb	replication	in	macrophages	ex	vivo,	but	appear	to	serve	a	limited	74	
antimicrobial	role	in	the	intact	animal	(14-16).			Instead,	a	subset	of	IFNg-inducible	cell-intrinsic	immune	75	
mechanisms,	known	as	Guanylate	binding	proteins	(GBPs),	target	and	disrupt	the	intracellular	niche	76	
required	for	a	number	of	pathogens	to	grow	(2,	17-21).	Macrophages	lacking	GBPs	1,	6,7	or	10	fail	to	77	
control	the	growth	of	M.	bovis	BCG,	an	attenuated	vaccine	strain	that	is	closely	related	to	Mtb	(22).		78	
Similarly,	mice	lacking	GBP1	or	the	cluster	of	5	GBP	proteins	on	chromosome	3	are	more	susceptible	to	79	
intravenous	BCG	challenge	(22,	23).		While	the	mechanism	of	BCG	control	remains	unclear,	GBPs	are	80	
known	to	bind	to	pathogen	containing	vacuoles	in	other	infections	and	recruit	additional	effector	81	
molecules	(17,	24).		The	outcome	of	this	recognition	can	be	the	direct	restriction	of	pathogen	growth	82	
and	alterations	in	cytokine	production.		While	these	observations	suggest	that	GBPs	may	be	an	83	
important	mediator	of	IFNg	-mediated	control	of	pathogenic	mycobacteria,	their	role	in	during	Mtb	84	
infection	has	remained	untested.		85	
BCG	was	attenuated	for	use	as	a	vaccine	via	long	term	serial	passage,	and	as	a	result,	it	interacts	86	
with	the	macrophage	quite	differently	from	Mtb	(25).		Most	notably,	the	primary	genetic	lesion	87	
responsible	for	the	attenuation	of	BCG	is	a	deletion	that	disrupts	the	ESX1	type	VII	secretion	system	(26).		88	
ESX1	is	specialized	protein	secretion	complex	that	contributes	to	pathogen	replication	by	remodeling	its	89	
intracellular	environment	(27).	ESX1	is	responsible	for	the	disruption	of	the	phagosomal	membrane,	the	90	
activation	of	multiple	cytosolic	immune	sensing	pathways,	and	stimulation	of	both	cytokine	secretion	91	
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and	autophagy	(28).		How	ESX1	alters	other	aspects	of	cell-intrinsic	bacterial	control	remains	to	be	92	
determined.			93	
To	understand	the	mechanisms	of	IFNg-mediated	protection	we	investigated	the	role	of	GBPs	94	
during	both	BCG	and	Mtb	infection.		Specifically,	we	examined	the	function	of	a	cluster	of	5	GBP	95	
proteins	that	are	encoded	in	a	single	locus	on	mouse	chromosome	3	(29).	While	these	GBPs	restricted	96	
M.	bovis	BCG	replication,	we	found	no	contribution	of	these	proteins	in	the	control	of	virulent	Mtb	97	
infection.	The	discrepant	effects	of	GBPs	during	BCG	and	Mtb	infection	could	be	attributed	to	98	
differential	ESX1	function	in	these	two	pathogens.		ESX1-deficient	strains	of	Mtb	were	better	controlled	99	
by	GBP-mediated	immunity,	while	GBP	deficiency	had	no	effect	on	either	the	growth	of	ESX1	expressing	100	
Mtb	or	the	immune	response	to	this	virulent	strain.		Together,	these	observations	indicate	that	the	ESX1	101	
system	plays	an	essential	role	in	the	evasion	of	GBP-mediated	cell	intrinsic	immunity.			102	
	103	
	 	104	
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Materials	and	Methods	105	
	106	
Mice	107	
C57BL/6J	(Stock	#	000664)	and	IFNgR-/-	(Stock	#	003288)	mice	were	purchased	from	the	Jackson	108	
Laboratory.	The	Gbpchr3-/-	mice	were	previously	described	(29).	All	knockout	mice	were	housed	and	bred	109	
under	specific	pathogen-free	conditions	and	in	accordance	with	the	University	of	Massachusetts	Medical	110	
School	IACUC	guidelines.	All	animals	used	for	experiments	were	6-12	weeks.		111	
	112	
Bacterial	Strains	113	
Wild	type	M.	tuberculosis	strain	H37Rv	was	used	for	all	studies	unless	indicated.	This	strain	was	114	
confirmed	to	be	PDIM-positive.	The	espA	(Rv3616c)	deletion	strain	(DespA)	was	a	gift	from	Dr.	Sarah	115	
Fortune	(30).	The	eccb1	(Rv3869)	deletion	strain	(Deccb1)	was	constructed	in	the	H37Rv	parental	116	
background	using	the	ORBIT	method	as	described	previously	(31).		The	live/dead	strain	was	built	by	117	
transforming	the	live/dead	vector	(pmV261	hsp60::mEmerald	tetOtetR::TagRFP)	into	H37Rv	and	118	
selected	with	hygromycin.	Protein	expression	was	confirmed	via	fluorescence	microscopy	and	flow	119	
cytometry.	H37Rv	expressing	msfYFP	has	been	previously	described	and	the	episomal	plasmid	was	120	
maintained	with	selection	in	Hygromycin	B	(50ug/ml)	added	to	the	media	(32).	Mycobacterium	bovis	121	
BCG	Danish	Strain	1331	(Statens	Serum	Institute,	Copenhagen,	Denmark)	was	used	for	all	BCG	infection	122	
studies.	Prior	to	infection	bacteria	were	cultured	in	7H9	medium	containing	10%	oleic	albumin	dextrose	123	
catalase	growth	supplement	(OADC)	enrichment	(Becton	Dickinson)	and	0.05%	Tween	80.	 124	
	125	
Mouse	Infection	126	
For	low	dose	aerosol	infections	(50-150	CFU),	bacteria	were	resuspended	in	phosphate-buffered	saline	127	
containing	tween	80	(PBS-T).	Prior	to	infection	bacteria	were	sonicated	then	delivered	via	the	128	
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respiratory	route	using	an	aerosol	generation	device	(Glas-Col).	For	mixed	infections,	bacteria	were	129	
prepared	then	mixed	1:1	before	aerosol	infection.		To	determine	CFU,	mice	were	anesthetized	via	130	
inhalation	with	isoflurane	(Piramal)	and	euthanized	via	cervical	dislocation,	the	organs	aseptically	131	
removed	and	individually	homogenized,	and	viable	bacteria	enumerated	by	plating	10-fold	serial	132	
dilutions	of	organ	homogenates	onto	7H10	agar	plates.	Plates	were	incubated	at	37C,	and	bacterial	133	
colonies	counted	after	21	days.	Both	male	and	female	mice	were	used	throughout	the	study	and	no	134	
significant	differences	in	phenotypes	were	observed	between	sexes.		135	
	136	
Flow	Cytometry	137	
Lung	tissue	was	harvested	in	DMEM	containing	FBS	and	placed	in	C-tubes	(Miltenyi).	Collagenase	type	138	
IV/DNaseI	was	added	and	tissues	were	dissociated	for	10	seconds	on	a	GentleMACS	system	(Miltenyi).	139	
Tissues	were	incubated	for	30	minutes	at	37C	with	oscillations	and	then	dissociated	for	an	additional	30	140	
seconds	on	a	GentleMACS.	Lung	homogenates	were	passaged	through	a	70-micron	filter	or	saved	for	141	
subsequent	analysis.	Cell	suspensions	were	washed	in	DMEM,	passed	through	a	40-micron	filter	and	142	
aliquoted	into	96	well	plates	for	flow	cytometry	staining.	Non-specific	antibody	binding	was	first	blocked	143	
using	Fc-Block.	Cells	were	then	stained	with	anti-Ly-6G	Pacific	Blue,	anti-CD11b	PE,	anti-CD11c	APC,	anti-144	
Ly-6C	APC-Cy7,	anti-CD45.2	PercP	Cy5.5,	anti-CD4	FITC,	anti-CD8	APC-Cy7,	anti-B220	PE-Cy7	(Biolegend).	145	
Live	cells	were	identified	using	fixable	live	dead	aqua	(Life	Technologies).	For	infections	with	fluorescent	146	
H37Rv,	lung	tissue	was	prepared	as	above	but	no	antibodies	were	used	in	the	FITC	channel.	All	of	these	147	
experiments	contained	a	non-fluorescent	H37Rv	infection	control	to	identify	infected	cells.	Cells	were	148	
stained	for	30	minutes	at	room	temperature	and	fixed	in	1%	Paraformaldehyde	for	60	minutes.	All	flow	149	
cytometry	was	run	on	a	MACSQuant	Analyzer	10	(Miltenyi)	and	was	analyzed	using	FlowJo_V9	(Tree	150	
Star).	151	
	152	
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Bone	marrow-derived	macrophage	generation		153	
To	generate	bone	marrow	derived	macrophages	(BMDMs),	marrow	was	isolated	from	femurs	and	tibia	154	
of	age	and	sex	matched	mice	as	previously	described	(33).	Cells	were	then	incubated	in	DMEM	(Sigma)	155	
containing	10%	fetal	bovine	serum	(FBS)	and	20%	L929	supernatant.	Three	days	later	media	was	156	
exchanged	with	fresh	media	and	seven	days	post-isolation	cells	were	lifted	with	PBS-EDTA	and	seeded	in	157	
DMEM	containing	10%	FBS	for	experiments.		158	
	 		159	
Macrophage	Infection	160	
Mtb	or	Mycobacterium	bovis-BCG	were	cultured	in	7H9	medium	containing	10%	oleic	albumin	dextrose	161	
catalase	growth	supplement	(OADC)	enrichment	(Becton	Dickinson)	and	0.05%	Tween	80.	Before	162	
infection	cultures	were	washed	in	PBS-T,	resuspended	in	DMEM	containing	10%FBS	and	centrifuged	at	163	
low	speeds	to	pellet	clumps.	The	supernatant	was	transferred	to	a	new	tube	to	ensure	single	cells.	164	
Multiplicity	of	infection	(MOI)	was	determined	by	optical	density	(OD)	with	an	OD	of	1	being	equivalent	165	
to	3x108	bacteria	per	milliliter.	Bacteria	were	added	to	macrophages	for	4	hours	then	cells	were	washed	166	
with	PBS	and	fresh	media	was	added.	At	the	indicated	time	points	supernatants	were	harvested	for	167	
cytokine	analysis	and	the	cells	were	processed	for	further	analysis.	For	cytokine	treatments	cells	were	168	
treated	with	the	indicated	concentrations	of	IFNg	(Peprotech)	or	vehicle	control	four	hours	following	169	
infection	and	maintained	in	the	media	throughout	the	experiment.	For	CFU	experiments	at	the	indicated	170	
timepoints	1%	saponin	was	added	to	each	well	and	lysates	were	serially	diluted	in	PBS	.05%	Tween	and	171	
plated	on	7H10	agar	and	colonies	were	counted	21-28	days	later.	For	the	Live/Dead	reporter	172	
experiments,	Anhydrotetracycline	(aTc)	(Cayman	Chemical)	was	added	to	a	final	concentration	of	173	
500ug/ml	24	hours	before	cells	were	lifted,	fixed	in	1%	Paraformaldehyde	and	analyzed	on	a	MacsQuant	174	
VYB	analyzer.		175	
	176	
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Cytokine	quantification	by	ELISA	177	
Murine	cytokine	concentrations	in	culture	supernatants	and	cell-free	lung	homogenates	were	quantified	178	
using	commercial	enzyme-linked	immunosorbent	assay	(ELISA)	kits	(R&D).	All	samples	were	normalized	179	
for	total	protein	content.		180	
Statistics.	GraphPad	Prism	version	7	was	used	for	all	statistical	analysis.	Unless	otherwise	indicated	one-181	
way	ANOVA	with	a	tukey	correction	was	used	to	compare	each	condition	to	each	genotype.		182	
 183	
	184	
	185	
	 	186	
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Results	187	
	188	
Mycobacterium	bovis	BCG	growth	is	restricted	by	the	Chromosome	3	Guanylate	binding	protein	189	
cluster.	190	
The	ten	murine	GBP	genes	are	encoded	in	two	clusters	on	chromosomes	3	and	5	(1).		To	begin	to	191	
address	the	potential	redundancy	between	these	genes,	we	used	mice	lacking	the	entire	chromosome	3	192	
cluster	that	contains	the	Gbp1	and	7	genes	that	were	previously	implicated	in	BCG	control,	along	with	193	
GBPs	2,	3,	and	5	(29).		To	determine	if	these	GBPs	contribute	to	control	of	mycobacterial	infection,	bone	194	
marrow-derived	macrophages	(BMDMs)	from	wild	type	and	Gbpchr3-/-	mice	were	infected	with	195	
Mycobacterium	bovis	BCG	(Figure	1A).		IFNg-treatment,	which	induces	GBP	expression,	reduced	the	196	
intracellular	bacterial	burden	in	wild	type	BMDMs.		In	contrast,	the	Gbpchr3-/-	deletion	significantly	197	
reduced	the	ability	of	macrophages	to	control	BCG	upon	IFNg	activation.	Thus,	GBPs	on	chromosome	3	198	
contribute	to	IFNg-mediated	restriction	of	BCG	in	macrophages.	199	
	 We	next	examined	if	GBPs	controlled	BCG	infection	in	the	context	of	an	intact	immune	200	
response.	Wild	type,	IFNgR-/-	and	Gbpchr3-/-		mice	were	infected	intravenously	with	BCG.	When	CFU	were	201	
quantified	in	the	spleen	50	days	later	we	observed	twenty-fold	more	BCG	in	IFNg	mice	and	five-fold	202	
more	BCG	in	Gbpchr3-/-		mice	compared	to	wild	type	controls	(Figure	1B).	The	increased	susceptibility	of	203	
IFNgR-/-	compared	to	Gbpchr3-/-		mice	indicated	that	the	function	of	these	GBPs	accounted	for	some	but	204	
not	all	of	the	protective	effect	of	IFNg.		Together	these	data	show	that	the	GBPs	on	chromosome	3	are	205	
able	to	restrict	the	growth	of	BCG	in	IFNg	-stimulated	macrophages	and	in	the	intact	animal,	which	is	206	
consistent	with	the	previously	described	roles	of	GBPs	in	immunity	to	BCG	(22,	23).	207	
	208	
Chromosome	3	GBP	cluster	does	not	control	Mycobacterium	tuberculosis	growth	in	macrophages.		209	
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To	determine	if	the	chromosome	3	GBPs	restricted	the	intracellular	growth	of	virulent	Mtb,	in	addition	210	
to	BCG,	we	quantified	the	growth	of	Mtb	strain	H37Rv	in	BMDMs	from	wild	type,	IFNgR-/-	and	Gbpchr3-/-		211	
animals	in	the	presence	and	absence	of	IFNg	(Figure	2A).	We	observed	no	differences	in	the	uptake	212	
between	genotypes	four	hours	following	infection.	IFNg	priming	reduced	the	intracellular	Mtb	growth	by	213	
3-4	fold	in	wild	type	macrophages,	but	not	IFNgR-/-		BMDMs	at	5	days	post	infection	(dpi).	In	contrast	to	214	
BCG,	we	observed	no	difference	in	Mtb	growth	in	Gbpchr3-/-		BMDMs	compared	to	wild	type	215	
macrophages	in	the	presence	or	absence	of	IFNg.		216	
	 To	ensure	that	the	relatively	insensitive	CFU-based	intracellular	growth	assay	did	not	mask	217	
subtle	effects	of	GBP	expression	on	bacterial	fitness,	we	used	a	fluorescent	live/dead	reporter	as	an	218	
orthologous	method	to	measure	Mtb	intracellular	viability	by	flow	cytometry.	This	reporter	expresses	a	219	
constitutive	mEmerald	and	an	anhydrotetracycline	(aTc)-inducible	tagRFP.	BMDMs	from	wild	type,	220	
IFNgR-/-		and	Gbpchr3-/-		mice	were	infected	with	the	Live/Dead	Mtb	reporter	and	left	untreated	or	were	221	
stimulated	with	IFNg.	Four	days	later	aTc	was	added	to	induce	tagRFP	expression	in	viable	intracellular	222	
bacteria.	The	following	day,	cells	were	analyzed	by	flow	cytometry	and	the	mean	fluorescence	intensity	223	
(MFI)	of	tagRFP	in	infected	mEmerald+	cells	was	quantified	(Figure	2B	and	2C).	Similar	to	the	CFU	224	
analysis,	IFNg	activation	reduced	the	intensity	of	tagRFP	to	a	similar	extent	in	both	wild	type	and	Gbpchr3-225	
/-		BMDMs,	and	this	reduction	depended	on	the	IFNg	receptor.	Thus,	we	were	not	able	to	detect	a	role	226	
for	the	chromosome	3	GBP	cluster	in	the	IFNg	mediated	restriction	of	virulent	Mtb	in	macrophages.		227	
	228	
Chromosome	3	GBPs	have	no	effect	on	Mtb	infection	in	intact	mice		229	
To	assess	the	role	of	the	chromosome	3	GBPs	in	the	more	complex	setting	of	the	intact	animal,	we	230	
infected	wild	type,	IFNgR-/-		and	Gbpchr3-/-		mice	with	Mtb	by	low	dose	aerosol	and	quantified	bacteria	in	231	
the	lungs	at	four	and	five	weeks	following	infection	(Figure	3A	and	3B).	IFNgR-/-	mice	harbored	more	Mtb	232	
than	wild	type	controls	at	both	time	points	in	the	lung	and	the	spleen.			In	contrast,	the	Mtb	burdens	in	233	
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Gbpchr3-/-			mice	were	indistinguishable	from	wild	type	animals	at	all	timepoints.	At	110	days	after	234	
infection	(Figure	3A	and	3B),	we	continued	to	find	no	difference	in	CFU	in	the	lungs	between	wild	type	235	
and	GBPchr3-/-		mice.	IFNgR-/-		mice	required	euthanasia	within	six	weeks	of	infection	and	were	not	236	
included	in	this	late	time	point.		237	
To	examine	more	subtle	differences	in	the	extent	of	infection,	wild	type,	IFNgR-/-		and	Gbpchr3-/-		238	
mice	were	infected	with	a	well-characterized	fluorescent	H37Rv	strain	by	low-dose	aerosol	(32).	Twenty-239	
eight	days	later	the	number	of	YFP+	cells	in	the	lung	environment	were	determined	by	flow	cytometry	240	
(Figure	3C).	Similar	to	our	CFU	results,	we	found	IFNgR	mice	contained	over	10	times	more	infected	cells	241	
than	wild	type	mice	while	Gbpchr3-/-		mice	showed	no	significant	difference	in	the	number	of	infected	242	
cells	per	lung	(Figure	3D).		243	
We	next	examined	if	there	were	differences	in	Gbpchr3-/-		mice	infected	intravenously	since	this	244	
route	matched	the	BCG	infections	where	the	role	of	GBPs	was	evident	(Figure	1B	and	(22)).		Following	245	
intravenous	infection	with	106	Mtb,	bacterial	levels	in	the	spleen	were	quantified	10	and	28	days	later.	246	
Similar	to	the	aerosol	infection	results,	we	saw	no	difference	between	Gbpchr3-/-		and	wild	type	animals,	247	
while	IFNgR-/-		animals	had	10	times	more	Mtb	growth	in	the	spleen	(Figure	3E).	Thus,	unlike	the	loss	of	248	
IFNgR,	the	loss	of	chromosome	3	GBPs	does	not	affect	Mtb	growth	in	the	lungs	or	spleen,	regardless	of	249	
infection	route,	suggesting	no	major	function	of	these	five	GBPs	in	controlling	antimicrobial	resistance	to	250	
Mtb	in	mice.		251	
	 		252	
Gbpchr3-/-	mice	continue	to	regulate	inflammatory	responses	to	Mtb	infection	253	
IFNg	protects	against	disease	both	by	restricting	bacterial	growth	and	by	inhibiting	tissue-damaging	254	
inflammation	(11).		To	determine	if	the	chromosome	3	GBPs	contribute	to	the	latter	immunoregulatory	255	
function	of	IFNg,	we	profiled	the	immune	responses	of	infected	macrophages	and	mice.		Wild	type	and	256	
GBPchrm3-/-	BMDMs	were	treated	with	IFNg	then	infected	with	Mtb	and	the	following	day	supernatants	257	
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were	harvested.		IFNg	signaling	showed	the	expected	inhibitory	effect	on	IL-1b	secretion,	but	the	258	
chromosome3	Gbp	deletion	had	no	effect	on	either	cytokine	(12).			We	next	profiled	the	host	response	259	
in	the	lungs	of	mice	to	determine	if	chromosome	3	GBPs	modulated	the	recruitment	of	immune	cells	or	260	
the	production	of	cytokines	during	Mtb	infection.	Wild	type,	IFNgR-/-		and	Gbpchr3-/-		mice	were	infected	261	
with	Mtb	and	four	weeks	later	we	quantified	the	immune	populations	in	the	lungs	by	flow	cytometry	262	
(Figure	4B).	While	we	observed	the	previously	described	increase	in	neutrophil	recruitment	in	IFNgR-/-		263	
mice,	we	observed	no	differences	in	any	myeloid	or	lymphoid	derived	cells	that	were	examined	between	264	
Gbpchr3-/-		and	wild	type	mice	(10).	We	also	quantified	IL1b	and	TNFa	in	the	lungs	from	these	infected	265	
animals	(Figure	4C).	The	production	of	these	cytokines	in	wild	type	and	GBPchrm3-/-	mice	were	266	
indistinguishable	while	IFNgR-/-	mice	showed	an	increase	in	IL1b.	Thus,	we	were	unable	to	detect	a	role	267	
for	GBPs	on	chromosome	3	in	controlling	the	host	response	during	virulent	Mtb	infection.		268	
	269	
ESX1	is	required	for	Mtb	to	evade	GBPs	of	chromosome	3.	270	
The	reduced	virulence	of	BCG	compared	to	Mtb	has	been	largely	attributed	to	the	loss	of	ESX1	function	271	
in	BCG.		As	a	result,	we	hypothesized	ESX1	function	in	virulent	Mtb	provides	resistance	to	GBP-mediated	272	
immunity,	and	its	loss	renders	BCG	susceptible	to	this	mechanism.		To	test	this	hypothesis,	we	273	
determined	whether	abrogation	of	ESX1	function	in	Mtb	would	result	in	a	strain	that	was	susceptible	to	274	
GBP-mediated	control.		Wild	type	and	Gbpchr3-/-		macrophages	were	infected	with	H37Rv	or	two	isogenic	275	
mutants	each	lacking	a	gene	that	is	necessary	for	ESX1	function,	DespA	or	Deccb1.	We	observed	that	276	
ESX1	mutants	displayed	reduced	intracellular	growth	compared	to	H37Rv	in	both	IFNg	stimulated	and	277	
unstimulated	wild	type	macrophages,	confirming	the	attenuation	of	these	mutants	(Figure	5A	and	5B).		278	
When	we	compared	wild	type	and	Gbpchr3-/-	BMDMs,	we	found	that	the	loss	of	GBP	function	had	no	279	
effect	on	H37Rv,	while	it	significantly	reduced	the	ability	of	IFNg	to	control	the	growth	of	both	ESX1	280	
mutants.		 	281	
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To	confirm	the	specific	effect	of	chromosome	3	GBPs	on	ESX1	mutants	in	the	setting	of	intact	282	
immunity,	we	conducted	a	competitive	infection	of	wild	type	and	Gbpchr3-/-		mice	with	an	equivalent	283	
number	of	H37Rv	and	Deccb1	bacteria.	Four	weeks	later	we	quantified	the	competitive	index	of	each	284	
bacterial	strain	in	the	lungs	(Figure	5C).	As	anticipated,	the	ratio	of	two	differentially	marked	H37Rv	285	
strains	stayed	constant	throughout	the	infection.		While	selection	in	wild	type	mice	resulted	in	almost	286	
100-fold	underrepresentation	of	the	Deccb1	mutant	compared	H37Rv,	the	fitness	defect	of	the	∆eccB1	287	
mutant	was	significantly	reduced	in	the	GBPchr3-/-	mice	(Figure	5C).		These	findings	demonstrate	that	288	
ESX1	deficiency	is	sufficient	to	render	Mtb	susceptible	to	GBP-mediated	immunity.		289	
	290	
	 	291	
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Discussion	292	
Understanding	the	immune	mechanisms	that	restrict	the	intracellular	growth	of	Mtb	is	essential	for	the	293	
rational	design	of	interventions.		Initial	observations	demonstrating	a	role	for	GBPs	in	the	control	of	BCG	294	
growth	suggested	that	this	pathway	might	represent	an	important	component	of	IFNg	-mediated	295	
immunity	to	Mtb	(22,	23).		However,	while	we	were	able	detect	the	previously-described	role	for	the	296	
chromosome	3	GBPs	in	immunity	to	BCG,	we	found	that	these	proteins	have	no	effect	during	Mtb	297	
infection.		By	attributing	this	difference	to	the	ESX1	locus	that	is	present	in	Mtb	but	not	BCG,	we	298	
discovered	a	specific	role	for	ESX1	in	overcoming	GBP-mediated	defenses.				299	
	300	
Our	findings	question	the	importance	of	GBPs	in	the	control	of	ESX1-expressing	Mtb.	While	our	results	301	
are	strictly	in	the	mouse	model,	evidence	in	humans	also	suggests	GBPs	may	not	effectively	control	TB	302	
progression.	For	example,	the	high	expression	of	a	subset	of	GBPs	is	predictive	of	patients	that	are	more	303	
likely	to	progress	to	active	disease	(34).		However,	it	is	important	to	note	that	it	remains	possible	that	304	
the	chromosome	5	GBPs,	or	human-specific	GBP	functions,	can	overcome	ESX1-mediated	bacterial	305	
defenses.		In	addition,	our	findings	do	not	rule	out	an	important	role	for	GBPs	in	resistance	to	non-306	
tuberculous	mycobacteria	(NTM).		While	all	mycobacteria	express	ESX	paralogs,	many	pathogenic	NTM	307	
do	not	possess	a	clear	ortholog	of	ESX1,	suggesting	that	they	may	remain	susceptible	to	GBP	immunity	308	
(35).			309	
	310	
How	the	ESX1	type	VII	secretion	system	allows	Mtb	to	evade	restriction	by	GBPs	remains	to	be	311	
investigated.	To	date,	the	type	III	secretion	system	effector	protein	IpaH9.8	from	Shigella	flexneri	is	the	312	
only	other	described	GBP	antagonist	(36-39).	In	the	cytosol	of	mammalian	cells,	where	S.	flexneri	313	
replicates,	IpaH9.8	targets	GBP1	for	degradation	thereby	interfering	with	direct	GBP	binding	to	the	314	
Shigella	outer	membrane,	a	process	by	which	GBP1	disrupts	the	function	of	a	membrane-bound	Shigella	315	
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virulence	factors	required	for	actin-based	motility	and	bacterial	dissemination	(36-38,	40).		Similar	to	316	
IpaH9.8,	ESX1	and	its	substrates	may	act	as	direct	GBP	antagonist	to	prevent	binding	to	Mycobacteria-317	
containing	vacuoles.	Alternatively,	ESX1	may	control	the	evasion	of	antimicrobial	mechanisms	that	occur	318	
subsequent	to	GBP	translocation	to	Mycobacteria-containing	vacuoles.	Future	work	will	need	to	dissect	319	
these	possible	mechanisms	for	ESX1-mediated	antagonism	of	GBP	function.	320	
	321	
While	IFNg	is	unquestionably	important	to	survive	Mtb	infection,	the	IFNg-mediated	pathways	that	322	
directly	control	the	intracellular	replication	of	Mtb	remain	surprisingly	unclear.	Our	results	add	to	a	323	
growing	list	of	direct	antimicrobial	pathways	that	are	ineffective	during	Mtb	infection.	The	IFNg-324	
mediated	production	of	nitric	oxide,	reactive	oxygen	species	and	itaconate	kills	many	pathogens;	325	
however,	these	mechanisms	appear	to	play	a	small	role	in	directly	controlling	Mtb	growth	in	vivo	(32,	326	
33,	41).	Instead,	these	mediators	are	required	to	inhibit	persistent	inflammation	and	to	prevent	disease	327	
progression.	In	addition,	the	IFNg-regulated	immunity	related	GTPases	(IRG)	family	protein,	Irgm1,	was	328	
originally	described	to	target	the	Mtb	containing	vacuole	to	control	pathogen	growth,	but	recent	329	
evidence	has	questioned	whether	Irgm1	targets	Mtb	phagosomes	(42,	43).	Instead,	the	lymphopenia	330	
observed	in	Irgm1-deficient	mice	may	be	predominantly	responsible	for	their	susceptibility	to	Mtb	331	
similar	to	other	pathogens	like	Chlamydia	trachomatis	(44,	45).	While	other	pathways	have	been	332	
suggested	to	play	a	role	in	IFNg-mediated	control,	including	the	production	of	Cathepsins,	the	role	of	333	
these	mediators	in	protection	in	vivo	remains	unclear	(46).	Overall,	our	findings	add	GBP-mediated	334	
immunity	to	the	list	of	IFNg	dependent	host	defense	programs	to	which	Mtb	has	evolved	specific	335	
counter	immune	mechanisms	blunting	the	effectiveness	of	these	antimicrobial	effectors	and	thus	336	
driving	pathogen	persistence	and	disease.		337	
	 	338	
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Figure	Legends.	344	
	345	
Figure	1.	Guanylate	binding	proteins	contribute	to	control	of	Mycobacterium	Bovis	BCG	infection.		(A)	346	
BMDMs	from	wild	type	or	Gbpchr3-/-	mice	were	infected	with	M.	Bovis	BCG	for	4	hours	then	washed	with	347	
fresh	media	in	the	presence	or	absence	of	IFNg.	Five	days	later	the	macrophages	were	lysed	and	serial	348	
dilutions	were	plated	to	quantify	colony	forming	units	(CFU)	of	viable	BCG.	Shown	is	the	mean	CFU	from	349	
four	biological	replicates	+/-	SD	*p<.05	**p<.01.	Data	are	representative	of	four	independent	350	
experiments.	(B)	Following	IV	infection	with	BCG	(1x106	bacteria)	the	total	bacterial	burden	(expressed	351	
in	CFU,	mean	+/-	SD)	was	determined	in	the	spleen	of	wild	type	of	Gbpchr3-/-	mice	50	days	following	352	
infection.	Representative	of	two	independent	experiments	with	4-5	mice	per	group,	*p<.05	**p<.01.	353	
	354	
Figure	2.	Mycobacterium	tuberculosis	is	resistant	to	chromosome	3	GBP-mediated	control	in	355	
macrophages.	(A)	BMDMs	from	wild	type,	IFNgR/-	or	Gbpchr3-/-	mice	were	infected	with	M.	tuberculosis	356	
for	4	hours	then	washed	with	fresh	media	in	the	presence	or	absence	of	IFNg.	Five	days	later	the	357	
macrophages	were	lysed,	serial	dilutions	were	plated	to	quantify	colony	forming	units	(CFU)	of	viable	M.	358	
tuberculosis.	Shown	is	the	mean	CFU	from	four	biological	replicates	+/-	SD	*p<.05	**p<.01.	Data	are	359	
representative	of	five	independent	experiments.	(B)	and	(C)	BMDMs	from	wild	type,	IFNgR/-	or	Gbpchr3-/-	360	
mice	were	infected	with	the	live/dead	reporter	M.	tuberculosis	for	4	hours	then	washed	with	fresh	361	
media	in	the	presence	or	absence	of	IFNg.	Four	days	later	aTc	was	added	to	each	well	at	a	final	362	
concentration	of	500ng/ml.	The	following	day	infected	cells	were	lifted	and	the	fluorescence	intensity	of	363	
the	inducible	Tet-on	TagRFP	was	determined	by	flow	cytometry.	Cells	were	gated	on	live	and	infected	364	
(mEmerald+)	cells.	(B)	A	representative	histogram	of	tagRFP	fluorescence	is	shown.	(C)	Shown	is	the	365	
mean	fluorescence	intensity	of	tagRFP	for	three	biological	replicates.	These	data	are	representative	of	366	
three	independent	experiments.	***p<.001.	367	
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	368	
Figure	3.	Mice	lacking	chromosome	3	GBPs	control	M.	tuberculosis	infection.	Following	low-dose	369	
aerosol	infection	with	H37Rv	(day	0	of	~50-150	CFU),	total	bacteria	(expressed	in	CFU,	mean	+/-	SD)	was	370	
determined	in	the	lungs	(A)	or	the	spleen	(B)	of	wild	type,	IFNgR-/-	or	Gbpchr3-/-	mice	at	the	indicated	time	371	
points	with	four	mice	per	group.	28	days	following	low-dose	aerosol	infection	with	sfYFP	H37Rv,	infected	372	
cells	in	the	lungs	of	wild	type,	IFNgR-/-	or	Gbpchr3-/-	mice	were	quantified	by	flow	cytometry.	(C)	Shown	is	373	
a	representative	flow	cytometry	plot	of	the	infected	cells	(YFP	positive)	that	are	gated	on	live,	single	cells	374	
and	(D)	the	mean	percent	of	YFP	positive	cells	in	the	lungs	of	infected	animals.	(E)	Following	intravenous	375	
infection	with	H37Rv	(1x106	per	mouse),	total	bacteria	were	determined	in	the	spleen	of	wild	type,	376	
IFNgR-/-	or	Gbpchr3-/-	mice	at	the	indicated	time	points	with	3-5	mice	per	group.	All	data	are	377	
representative	of	3	independent	experiments.				378	
	379	
Figure	4.	Chromosome	3	GBPs	do	not	control	the	host	response	to	M.	tuberculosis	infection.	(A)	380	
BMDMs	from	wild	type,	IFNgR/-	or	Gbpchr3-/-	mice	were	stimulated	with	IFNg	overnight	then	infected	with	381	
Mtb	for	4	hours	then	washed	with	fresh	media.	18	hours	later,	supernatants	were	harvested	and	the	382	
levels	of	IL1b	and	TNFa	were	quantified	in	the	supernatants	by	ELISA.	Shown	is	the	mean	of	four	383	
biological	replicates	normalized	to	a	standard	curve	+/-	SD	*p<.05.	(B)	and	(C)	28	days	following	low-384	
dose	aerosol	infection	with	H37Rv	(day	0	of	~50-100	CFU),	the	lungs	of	wild	type,	IFNgR/-,	and	Gbpchr3-/-	385	
mice	were	harvested	and	the	immune	cell	populations	were	quantified	by	flow	cytometry	and	cytokines	386	
were	quantified	by	ELISA.	For	(B),	we	determined	the	%	of	live	cells	for	Granulocytes	(CD45+	CD11b+	387	
Ly6G+),	Macrophages	(CD45+	CD11b+	Ly6G-),	Dendritic	Cells	(CD45+	CD11b-	Ly6G-	CD11c+),	CD4+	T	cells	388	
(CD45+	CD4+),	CD8+	T	cells	(CD45+	CD8+)	and	B	cells	(CD45+	B220+).	For	(C)	Cytokines	quantified	from	lung	389	
homogenates.	Shown	is	the	mean	of	three	mice	per	group	+/-	SD	*p<.05.	These	data	are	representative	390	
of	3-4	independent	experiments	with	similar	results.	391	
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Figure	5.	M.	tuberculosis	ESX1	mutants	are	susceptible	to	GBP-mediated	control.	(A)	BMDMs	from	wild	393	
type	or	Gbpchr3-/-mice	were	infected	with	M.	tuberculosis	H37Rv,	DespA	(Left)	or	Deccb1	(Right)	for	4	394	
hours	then	washed	with	fresh	media	in	the	presence	or	absence	of	IFNg.	Five	days	later	the	395	
macrophages	were	lysed	and	serial	dilutions	were	plated	to	quantify	colony	forming	units	(CFU)	of	viable	396	
M.	tuberculosis.	Shown	is	the	mean	CFU	from	four	biological	replicates	+/-	SD	*p<.05	**p<.01	by	two-397	
tailed	t-test.	Data	are	representative	of	two	independent	experiments	with	similar	results.	(B)	Following	398	
low-dose	aerosol	infection	with	a	1:1	mixed	infection	of	either	H37Rv	(Hyg):H37Rv	(Kan)	or	Deccb1	399	
(Hyg):	H37Rv	(Kan)	(day	0	of	~100-200	CFU),	total	bacteria	in	the	lungs	that	were	either	Kan	or	Hyg	400	
resistant	were	quantified.	The	competitive	index	was	calculated	(Hyg	CFU/Kan	CFU)	and	is	shown	as	the	401	
mean	for	3	independent	mice	for	each	genotype	combination.	The	data	are	representative	of	two	402	
independent	experiments	with	similar	results.	403	
	 	404	
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